Human glycogenins maintain glucose homeostasis by regulating glycogen metabolism

Tzu‐Han Weng, Yu-Chung Pien, Ching-Jou Chen, Po-Pang Chen, Yu‐Ting Tseng, Chung‐Cheng Chen, Wen-Po Hsiao, Ying-Ting Lee, Yian Chen, Yanxing Chen, Carmay Lim, Tzu-Han Hsu, Sung‐Jan Lin, Hsin‐Yung Yen, Kuo‐Chiang Hsia, Su‐Yi TsaiNature Communications 2025 · DOI

TL;DR

This paper reveals that human glycogenins, GYG1 and GYG2, have distinct and crucial roles in maintaining blood glucose balance. GYG1 initiates glycogen synthesis, while GYG2 acts as a brake, suppressing it and influencing the structure of glycogen particles. This discovery sheds light on metabolic disorders and offers potential therapeutic avenues.

What Problem Does This Paper Address?

Glycogen is our body's primary energy storage molecule, but how its synthesis and structure are precisely controlled, especially across different tissues, remains a puzzle. Disruptions in this process are linked to serious metabolic issues like glycogen storage diseases and diabetes. While we know glycogenin is involved in starting glycogen synthesis, the specific roles of the two human glycogenin isoforms, GYG1 and GYG2, and how they work together to maintain glucose homeostasis were unclear. This paper aims to unravel these distinct physiological roles and their impact on cellular energy balance.

Methods

The researchers employed a multi-pronged approach:

  • Cellular Models: They used human embryonic stem cells (hESCs) and differentiated them into various cell types (hepatocytes, cardiomyocytes, neurons, skeletal muscle) to study GYG1 and GYG2 function in different cellular contexts. They also created knockout (KO) cell lines for GYG1, GYG2, and both (DKO) to investigate their specific contributions.
  • Structural Biology: Cryo-electron microscopy (cryo-EM) was used to determine the structure of the GS-GYG2 complex, providing atomic-level insights into their interaction.
  • Biochemical Analyses: Techniques like Western blotting, Periodic Acid-Schiff (PAS) staining (to visualize glycogen), glycogen content assays, autoglycosylation assays, and enzyme activity assays were used to quantify and characterize the roles of GYG1 and GYG2.
  • Metabolic Profiling: Seahorse assays were used to measure cellular respiration and glycolysis, while 13C-labeled glucose tracing and mass isotopomer distribution analysis helped understand metabolic flux and pathway utilization in different cell lines.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • GYG2 is a Suppressor, Not Just a Backup: Contrary to some assumptions, GYG2 doesn't simply compensate for GYG1. Instead, it actively suppresses glycogen synthesis by interacting with the inactive form of glycogen synthase (GS).
  • Structural Control of Glycogen: GYG2 plays a critical role in determining the size and structure of glycogen particles, influencing whether they are compact or more branched. This structural aspect is key to efficient energy storage and release.
  • Cell-Type Specificity is Crucial: The roles of GYG1 and GYG2, and their interactions with GS, vary significantly depending on the cell type. This highlights the intricate tissue-specific regulation of glycogen metabolism.
  • Metabolic Sensor Role of GYG2: GYG2 appears to act as a metabolic sensor, its expression and activity dynamically changing in response to glucose availability, fine-tuning glycogen synthesis and breakdown.

Key Results

  • GYG1 KO cells show reduced glycogen: Knocking out GYG1 in hESCs significantly reduced glycogen content.
  • GYG2 KO cells show increased glycogen: Conversely, GYG2 knockout led to higher glycogen accumulation.
  • GYG2 has minimal autoglycosylation: Unlike GYG1, GYG2 has a very limited ability to initiate glycogen synthesis by adding glucose to itself.
  • GYG2 influences GS phosphorylation: GYG2 binding to GS promotes GS phosphorylation, leading to its inactivation.
  • Structural differences impact function: Cryo-EM revealed that the GS-GYG2 complex adopts an inactive conformation, and structural analysis points to differences in the "C-loop" region of GYG2 as a reason for its reduced autoglycosylation activity.
  • Metabolic shifts in KO cells: GYG1 KO cells showed increased oxygen consumption and reliance on glycolysis, while GYG2 KO cells exhibited increased glycogen accumulation and a shift towards glycolysis.
  • Glycogen particle size control: GYG2 deficiency led to smaller, less structured glycogen particles, while its overexpression reduced overall glycogen content.

Limitations and Future Work

  • In Vitro vs. In Vivo: While the study uses cell models, further in vivo studies are needed to fully elucidate the physiological relevance of these findings in whole organisms.
  • Therapeutic Potential: The paper suggests that targeting GYG1 and GYG2 could be a therapeutic strategy for GSDs and diabetes, but this requires further investigation and validation.
  • Complex Interactions: The precise mechanisms by which GYG2 influences GS phosphorylation and particle assembly, especially in different cellular environments, warrant deeper exploration.
  • PPARG-GYG2 Axis: The study hints at a PPARG-GYG2 regulatory axis influencing metabolic regulation, which could be a promising area for future research.

Summary updated

Abstract

Proper regulation of glycogen metabolism is fundamental to cellular energy homeostasis, and its disruption is associated with various metabolic disorders, including glycogen storage diseases (GSDs) and potentially diabetes. Despite glycogen's role as an essential energy reservoir, the mechanisms governing its synthesis and structural diversity across tissues remain unclear. Here, we uncover the distinct physiological roles of the human glycogenins GYG1 and GYG2 in glycogen synthesis. Through cellular models, structural biology, and biochemical analyses, we demonstrate that, unlike GYG1, GYG2 exhibits minimal autoglycosylation activity and acts as a suppressor of glycogen formation. Together, these two glycogenins coordinate glycogen synthase activity and influence glycogen assembly in a cell-type-dependent manner. Importantly, these glycogenins modulate glucose metabolic pathways, thereby ensuring cellular glucose homeostasis. These findings address longstanding questions in glycogen metabolism and establish both GYG1 and GYG2 as critical regulators of glycogen synthesis and breakdown in human, providing insights with potential therapeutic implications for treating GSDs and metabolic diseases.
BibTeX
@inproceedings{weng2025human,
  author = {Tzu‐Han Weng and Yu-Chung Pien and Ching-Jou Chen and Po-Pang Chen and Yu‐Ting Tseng and Chung‐Cheng Chen and Wen-Po Hsiao and Ying-Ting Lee and Yian Chen and Yanxing Chen and Carmay Lim and Tzu-Han Hsu and Sung‐Jan Lin and Hsin‐Yung Yen and Kuo‐Chiang Hsia and Su‐Yi Tsai},
  title = {{Human glycogenins maintain glucose homeostasis by regulating glycogen metabolism}},
  booktitle = {Nature Communications},
  year = {2025},
  doi = {10.1038/s41467-025-61862-3},
}
Figure